Internal Medicine, Medical Oncology · East Brunswick, NJ
NPI
1811986706
Since 2005
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
629 Cranbury Rd Fl 2
East Brunswick, NJ, 08816
Phone (732) 390-7750
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
153,327 services
Medicare patients, 2024
800
Average age 75
Drug cost, 2024
$4.2M
1,674 prescriptions
Company payments, 2025
$199
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James C Salwitz was code J1439 (injection, ferric carboxymaltose, 1 mg), 52,500 times for 49 patients. In total James C Salwitz billed 153,327 services in 153 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 52,500 | 49 | $0.87 | $46K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,600 | 13 | $44.78 | $296K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 5,080 | 11 | $2.35 | $12K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,026 | 20 | $21.24 | $86K |
| J0897 Injection, denosumab, 1 mg | Office | 3,780 | 16 | $20.73 | $78K |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 2,380 | 16 | $35.83 | $85K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,456 | 40 | $0.09 | $131 |
| 36415 Venipuncture Blood Collection | Office | 962 | 422 | $8.64 | $8,313 |
| 99214 Office E&M - Established | Office | 919 | 399 | $109.45 | $101K |
| 85027 Blood Count | Office | 650 | 173 | $6.31 | $4,102 |
| 96372 Injection Administration | Office | 497 | 125 | $12.70 | $6,310 |
| 85025 Blood Count | Office | 362 | 152 | $7.59 | $2,747 |
| 99213 Office E&M - Established | Office | 318 | 224 | $79.92 | $25K |
| 96367 Intravenous Infusion, Hydration | Office | 307 | 76 | $26.71 | $8,200 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 269 | 106 | $14.15 | $3,807 |
By year: 2022 $1.9M for 127,842 services; 2023 $2.2M for 148,187 services; 2024 $2.5M for 153,327 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 962 | 422 | $8.64 | $8,313 |
| 85027 Blood Count | 650 | 173 | $6.31 | $4,102 |
| 85025 Blood Count | 362 | 152 | $7.59 | $2,747 |
Medicare prescription drug claims, 2024
In 2024, the drug James C Salwitz prescribed most often to Medicare patients was Alprazolam, with 107 prescriptions and refills. In total James C Salwitz wrote 1,674 Medicare prescriptions that cost $4.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 107 | 119 | 28 | $694 |
| Prednisone Generic | 105 | 137 | 36 | $562 |
| Anastrozole Generic | 91 | 270 | 30 | $2,092 |
| Eliquis Apixaban | 62 | 89 | 13 | $50K |
| Procrit Epoetin Alfa | 60 | 60 | Under 11 | $105K |
| Aranesp Darbepoetin Alfa In Polysorbat | 58 | 58 | Under 11 | $139K |
| Oxycodone Hcl Generic | 50 | 50 | 13 | $854 |
| Imbruvica Ibrutinib | 40 | 40 | Under 11 | $548K |
| Letrozole Generic | 38 | 98 | 12 | $1,109 |
| Xarelto Rivaroxaban | 33 | 81 | 11 | $41K |
| Ondansetron Odt Ondansetron | 33 | 33 | 16 | $500 |
| Ibrance Palbociclib | 31 | 31 | Under 11 | $451K |
| Levothyroxine Sodium Generic | 30 | 87 | Under 11 | $422 |
| Gabapentin Generic | 30 | 48 | Under 11 | $503 |
| Somatuline Depot Lanreotide Acetate | 25 | 25 | Under 11 | $225K |
Brand drugs: - claims; generic drugs: 1,094 claims; opioid claims: 137.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James C Salwitz $199 ($199 in general payments such as food, travel and fees) from 9 companies. The largest payer was Abbvie Inc. with $52.23.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 3 | $52.23 |
| Aveo Pharmaceuticals, Inc. | 1 | $27.59 |
| Pfizer Inc. PFE | 1 | $19.49 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $18.8 |
| Deciphera Pharmaceuticals Inc. | 1 | $17.81 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $17.01 |
| Astellas Pharma US Inc 4503.T | 1 | $16.27 |
| Gilead Sciences, Inc. GILD | 1 | $16.17 |
| Blueprint Medicines Corporation SNY | 1 | $14.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.